摘要
目的对比观察采用低分子肝素钙预防肥胖患者妇科腹腔镜手术后下肢深静脉血栓形成(DVT)的临床效果。方法将2003年7月～2007年4月肥胖且行妇科腹腔镜手术的患者随机分为未用药组和用药组,其中用药组203例,围手术期给予低分子肝素钙预防,未用药组178例。2组患者均根据术后临床症状、彩色超声检查及静脉造影来诊断DVT。结果用药组DVT发生率为1.5%(3/203),非用药组DVT发生率为3.4%(6/178),2组相比差异有显著性(P<0.05)。结论低分子肝素钙可显著降低肥胖患者妇科腹腔镜术后下肢深静脉血栓的发生率,而且具有良好的安全性。
[Objective] To compare and observe the clinical results of Low Molecular Heparin in preventing deep venous thrombosis after gynaecological laparoscopic operation in fat patients. [Method] Fat patients from 2003.7- 2007.4 were randomly divided as no-medication group and medication group. There were 203 patients in medication group, treated with Low Molecular Heparin in perioperative time and 178 patients in no-medication group. Deep venous thrombosis was diagnosed according to postoperation clinical symptom, color ultrasonograph and phlebography in two groups. [Result] DVT incidence rate was 1.5% （3/203） in medication group; DVT incidence rate was 3.41% （6/178） in no-medication group; there was. a significance statistical difference （P 〈0.05）. [ Conclusion ] Low Molecular Heparin can significantly degrade DVT incidence rate of fat patients after gynaecological laparoscopic operation. It has satisfactory safety.
出处
《中国内镜杂志》
CSCD
北大核心
2008年第3期266-268,共3页
China Journal of Endoscopy
关键词
血栓性静脉炎
肥胖
腹腔镜
肝素
低分子量
thrombophlebitis
fat
laparoscope
heparin
low molecular number
